Onclarity Self-Collection Kit— 510(k) K260184
Substantially EquivalentBecton, Dickinson and Company
FDA 510(k) clearance K260184 for Onclarity Self-Collection Kit, Substantially Equivalent on 2026-04-02. Applicant: Becton, Dickinson and Company.
Clearance details
- Applicant
- Becton, Dickinson and Company
- Product code
- Code SEP
- Advisory panel
- Microbiology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Sparks, MD, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.